bpc-157 dosing studies humans clinical trials dosage BPC-157 (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or Home BPC-157 Calculator: Dose, Units,

For musculoskeletal injuries, subcutaneous injection near the injury site is generally preferred because it delivers the peptide directly to the damaged tissue

The net result is increased bone mass and density

Enhanced blood flow can contribute to faster recovery and improved healing outcomes

Data Availability Statement The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Good candidates for B12 injections include individuals with B12 deficiency symptoms, vegetarians, older adults, and those with gastrointestinal issues affecting B12 absorption